Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionTruvestments Capital Llc
Latest Disclosed Ownership2,247 shares
Latest Disclosed Value $ 313,171
Truvestments Capital Llc reports 1.36% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 13, 2026 - Truvestments Capital Llc filed a 13F-HR form disclosing ownership of 2,247 shares of Gilead Sciences, Inc. (CH:GILD) valued at $313,171 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,278 shares of Gilead Sciences, Inc.. This represents a change in shares of -1.36% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,247 -31 -1.36 313 12.19 0.0565
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,278 261 12.94 280 25.11 0.0508
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,017 -532 -20.87 224 -20.92 0.0405
2025-08-13 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,549 -64 -2.45 283 -3.42 0.0565
2025-05-14 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,613 1,010 63.01 293 97.30 0.0636
2025-02-10 2024-12-31 13F GILEAD SCIENCES COM 375558103 1,603 104 6.94 148 18.40 0.0381
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 1,499 1,499 126 0.0337
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 0 -1,476 -100.00 0 -100.00
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 1,476 85 6.11 108 -3.57 0.0416
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 1,391 775 125.81 113 143.48 0.0509
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 616 -14 -2.22 46 -4.17 0.0240
2023-08-10 2023-06-30 13F GILEAD SCIENCES COM 375558103 630 175 38.46 49 29.73 0.0242
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 455 -237 -34.25 38 -37.29 0.0201
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 692 37 5.65 59 47.50 0.0335
2022-11-15 2022-09-30 13F GILEAD SCIENCES COM 375558103 655 -199 -23.30 40 -24.53 0.0252
2022-08-09 2022-06-30 13F GILEAD SCIENCES COM 375558103 854 854 53 0.0310
2022-05-02 2022-03-31 13F GILEAD SCIENCES COM 375558103 0 -849 -100.00 0 -100.00
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 849 457 116.58 62 129.63 0.0311
2021-10-29 2021-09-30 13F GILEAD SCIENCES COM 375558103 392 2 0.51 27 0.00 0.0149
2021-08-12 2021-06-30 13F GILEAD SCIENCES COM 375558103 390 -1,894 -82.92 27 -81.76 0.0148
2021-05-18 2021-03-31 13F GILEAD SCIENCES INC COM COM 375558103 2,284 2 0.09 148 12.12 0.0836
2021-02-17 2020-12-31 13F GILEAD SCIENCES INC COM COM 375558103 2,282 564 32.83 132 21.10 0.0916
2020-11-13 2020-09-30 13F GILEAD SCIENCES INC COM COM 375558103 1,718 33 1.96 109 -15.50 0.0985
2020-08-06 2020-06-30 13F GILEAD SCIENCES INC COM COM 375558103 1,685 -346 -17.04 129 -14.57 0.1315
2020-05-07 2020-03-31 13F GILEAD SCIENCES INC COM COM 375558103 2,031 2,031 151 0.1919
2020-01-29 2019-12-31 13F GILEAD SCIENCES COM 375558103 0 -1,627 -100.00 0 -100.00
2019-10-10 2019-09-30 13F GILEAD SCIENCES COM 375558103 1,627 2 0.12 103 -6.36 0.0671
2019-07-15 2019-06-30 13F GILEAD SCIENCES COM 375558103 1,625 -128 -7.30 110 -3.51 0.0740
2019-04-12 2019-03-31 13F GILEAD SCIENCES COM 375558103 1,753 -973 -35.69 114 -45.71 0.0875
2018-10-22 2018-09-30 13F GILEAD SCIENCES COM 375558103 2,726 2,726 210 0.1010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.